Quadrant Capital Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,258
| Closed | -$154K | – | 1344 |
|
|
2025
Q1 | $154K | Buy |
+9,258
| New | +$154K | 0.01% | 1410 |
|
|
2024
Q4 | – | Sell |
-205
| Closed | -$3.15K | – | 2734 |
|
|
2024
Q3 | $3.15K | Buy |
+205
| New | +$3.15K | ﹤0.01% | 2417 |
|
|
2022
Q4 | – | Sell |
-435
| Closed | -$7K | – | 2733 |
|
|
2022
Q3 | $7K | Buy |
435
+369
| +559% | +$5.94K | ﹤0.01% | 1999 |
|
|
2022
Q2 | $1K | Sell |
66
-44
| -40% | -$667 | ﹤0.01% | 2309 |
|
|
2022
Q1 | $2K | Sell |
110
-79
| -42% | -$1.44K | ﹤0.01% | 2118 |
|
|
2021
Q4 | $4K | Buy |
189
+47
| +33% | +$995 | ﹤0.01% | 1926 |
|
|
2021
Q3 | $2K | Sell |
142
-418
| -75% | -$5.89K | ﹤0.01% | 2098 |
|
|
2021
Q2 | $14K | Buy |
560
+427
| +321% | +$10.7K | ﹤0.01% | 1374 |
|
|
2021
Q1 | $3K | Buy |
133
+27
| +25% | +$609 | ﹤0.01% | 1923 |
|
|
2020
Q4 | $6K | Buy |
106
+65
| +159% | +$3.68K | ﹤0.01% | 1610 |
|
|
2020
Q3 | $2K | Buy |
+41
| New | +$2K | ﹤0.01% | 1781 |
|
|
2020
Q2 | – | Sell |
-968
| Closed | -$41K | – | 2199 |
|
|
2020
Q1 | $41K | Sell |
968
-181
| -16% | -$7.67K | 0.01% | 958 |
|
|
2019
Q4 | $48K | Buy |
1,149
+181
| +19% | +$7.56K | 0.01% | 1354 |
|
|
2019
Q3 | $34K | Hold |
968
| – | – | 0.01% | 1376 |
|
|
2019
Q2 | $25K | Buy |
+968
| New | +$25K | ﹤0.01% | 1544 |
|
|
2017
Q1 | – | Sell |
-2,345
| Closed | -$67K | – | 2057 |
|
|
2016
Q4 | $67K | Sell |
2,345
-236
| -9% | -$6.74K | 0.03% | 351 |
|
|
2016
Q3 | $81K | Buy |
2,581
+2,351
| +1,022% | +$73.8K | 0.05% | 294 |
|
|
2016
Q2 | $7K | Buy |
+230
| New | +$7K | ﹤0.01% | 1111 |
|
|
2016
Q1 | – | Sell |
-179
| Closed | -$6K | – | 1791 |
|
|
2015
Q4 | $6K | Buy |
+179
| New | +$6K | ﹤0.01% | 959 |
|